無料プレビュー

Sanofi (SNY) · NASDAQ Global Select

プロフィール

Sanofi is an R&D-driven biopharma company that discovers, develops, manufactures, and commercializes medicines and vaccines across specialty care, general medicines, and vaccines franchises. It applies immunology expertise to create treatments and preventive products serving patients worldwide. The company operates primarily through a single Biopharma segment encompassing research, development, production, and commercial operations across all therapeutic franchises and geographies, with recent divestitures including the sale of a controlling stake in Opella consumer healthcare to CD&R in April

主要指標

株価: $40.23 (+0.07%)
時価総額: 966億ドル
PER（今期予想）: 8.6
PBR: 1.2
配当利回り: 6.01%
52週レンジ: $39.18 – $52.68
業種: Healthcare / Drug Manufacturers - General
上場: NASDAQ Global Select
構成銘柄: —

比較会社: LLY Eli Lilly and Company、JNJ Johnson & Johnson、ABBV AbbVie Inc.、MRK Merck & Co., Inc.、NVS Novartis AG、AZN AstraZeneca PLC、AMGN Amgen Inc.、GILD Gilead Sciences, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-30 · 更新: 2026-10-09